Apr 19, 2021

Call to Action - April 19, 2021 - Astra Zeneca / COVIDSHIELD Eligibility Criteria, Updated Resources and Webinar for Treatment and Reporting of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

Apr 7, 2021

Call to Action - April 7, 2021 - Precision AIR Respirator Resources

Apr 6, 2021

Call to Action - April 6, 2021 - Diagnostic Imaging Referrals Post COVID-19 Vaccine

Mar 31, 2021

Call to Action - March 31, 2021 - IP+C Guidance for Spring Celebration, Staff Booster Session - Wellness Workday

Mar 30, 2021

Call to Action - March 30, 2021 - Pause use of AstraZeneca / COVISHIELD in People aged < 55 years

Mar 26, 2021

Call to Action - March 26, 2021 - Updated Astra Zeneca and COVISHIELD Product Monographs, Health Product Risk Communication and Resources

Mar 22, 2021

Call to Action - March 22, 2021 - New / Updated Communication Products Including Clinical Practice Guidelines and Consent Forms, New or Updated Resources for the General Public, HPS COVID-19 Reminder

Mar 15, 2021

Call to Action - March 15, 2021 - Change to Masking in Acute Care Facilities and Personal Care Homes

Mar 11, 2021

Call to Action - March 11, 2021 - Occurrence Reporting Requirements, Essential Travelers and Primary Care Services

Mar 9, 2021

Call to Action - March 9, 2021 - COVID-19 Infection and Pregnancy

Mar 3, 2021

Call to Action - March 3, 2021 - COVID-19 Positive Mental Health Patients Requiring Acute Mental Health Admissions from Outside of Winnipeg

Feb 24, 2021

Call to Action - February 24, 2021 - Point of Care Risk Assessment Poster

Feb 22, 2021

Call to Action - February 22, 2021 - Staff Booster Session - Managing COVID-19 Information Overload

Feb 18, 2021

Call to Action - February 18, 2021 - Precision Air N95

Feb 17, 2021

Call to Action - February 17, 2021 - Variants of Concern, Alternative Isolation Accommodation